| Universal definition of myocardial infarction K Thygesen, JS Alpert, HD White Journal of the American College of Cardiology 50 (22), 2173-2195, 2007 | 6387 | 2007 |
| Ticagrelor versus clopidogrel in patients with acute coronary syndromes L Wallentin, RC Becker, A Budaj, CP Cannon, H Emanuelsson, C Held, ... New England Journal of Medicine 361 (11), 1045-1057, 2009 | 5862 | 2009 |
| ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European … Ž Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ... European heart journal 32 (14), 1769-1818, 2011 | 4855* | 2011 |
| ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ... European heart journal 32 (23), 2999-3054, 2011 | 4182 | 2011 |
| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute … M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ... European heart journal 37 (3), 267-315, 2016 | 3831 | 2016 |
| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 1194 | 2015 |
| CLINICAL PERSPECTIVE PA Gurbel, KP Bliden, K Butler, US Tantry, T Gesheff, C Wei, R Teng, ... Circulation 120 (25), 2577-2585, 2009 | 1153 | 2009 |
| 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... European journal of cardio-thoracic surgery 53 (1), 34-78, 2017 | 967* | 2017 |
| ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European … AL Catapano, Ž Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ... Atherosclerosis 217, 1-44, 2011 | 931 | 2011 |
| Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the … L Wallentin, S James, RF Storey, M Armstrong, BJ Barratt, J Horrow, ... The Lancet 376 (9749), 1320-1328, 2010 | 704 | 2010 |
| Thrombin-receptor antagonist vorapaxar in acute coronary syndromes P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ... New England Journal of Medicine 366 (1), 20-33, 2012 | 693 | 2012 |
| Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study CP Cannon, RA Harrington, S James, D Ardissino, RC Becker, ... The Lancet 375 (9711), 283-293, 2010 | 662 | 2010 |
| Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non–ST … CP Cannon, S Husted, RA Harrington, BM Scirica, H Emanuelsson, ... Journal of the American College of Cardiology 50 (19), 1844-1851, 2007 | 562 | 2007 |
| Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies PA Gurbel, KP Bliden, K Butler, MJ Antonino, C Wei, R Teng, ... Circulation 121 (10), 1188-1199, 2010 | 550 | 2010 |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a … Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ... European heart journal 35 (45), 3155-3179, 2014 | 533 | 2014 |
| Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient … C Held, N Åsenblad, JP Bassand, RC Becker, CP Cannon, MJ Claeys, ... Journal of the American College of Cardiology 57 (6), 672-684, 2011 | 511 | 2011 |
| Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet … PG Steg, S James, RA Harrington, D Ardissino, RC Becker, CP Cannon, ... Circulation 122 (21), 2131-2141, 2010 | 498 | 2010 |
| Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes RF Storey, S Husted, RA Harrington, S Heptinstall, RG Wilcox, G Peters, ... Journal of the American College of Cardiology 50 (19), 1852-1856, 2007 | 488 | 2007 |
| Prehospital ticagrelor in ST-segment elevation myocardial infarction G Montalescot, AW Van't Hof, F Lapostolle, J Silvain, JF Lassen, ... New England Journal of Medicine 371 (11), 1016-1027, 2014 | 473 | 2014 |
| Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline … S James, A Åkerblom, CP Cannon, H Emanuelsson, S Husted, H Katus, ... American heart journal 157 (4), 599-605, 2009 | 415 | 2009 |
